These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection. Abdallah AN; Cucchi-Mouillot P; Biteau N; Cassaigne A; Haras D; Iron A Eur J Immunogenet; 1999 Aug; 26(4):249-55. PubMed ID: 10457886 [TBL] [Abstract][Full Text] [Related]
6. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection. Pawlik A; Domanski L; Rozanski J; Florczak M; Dabrowska-Zamojcin E; Dutkiewicz G; Gawronska-Szklarz B Transplant Proc; 2005 Jun; 37(5):2041-3. PubMed ID: 15964333 [TBL] [Abstract][Full Text] [Related]
7. The association between cytokine gene polymorphisms and kidney allograft survival. Pawlik A; Domanski L; Rozanski J; Czerny B; Juzyszyn Z; Dutkiewicz G; Myslak M; Hałasa M; Słojewski M; Dabrowska-Zamojcin E Ann Transplant; 2008; 13(2):54-8. PubMed ID: 18566561 [TBL] [Abstract][Full Text] [Related]
8. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts. Evans PC; Smith S; Hirschfield G; Rigopoulou E; Wreghitt TG; Wight DG; Taylor CJ; Alexander GJ J Hepatol; 2001 May; 34(5):711-5. PubMed ID: 11434617 [TBL] [Abstract][Full Text] [Related]
9. Impaired kidney graft survival is associated with the TNF-alpha genotype. Wramner LG; Norrby J; Hahn-Zoric M; Ahlmén J; Börjesson PA; Carlström J; Hytönen AM; Olausson M; Hanson LA; Padyukov L Transplantation; 2004 Jul; 78(1):117-21. PubMed ID: 15257049 [TBL] [Abstract][Full Text] [Related]
10. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Fernandes H; Koneru B; Fernandes N; Hameed M; Cohen MC; Raveche E; Cohen S Transplantation; 2002 Jun; 73(12):1886-91. PubMed ID: 12131682 [TBL] [Abstract][Full Text] [Related]
11. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device. Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alfa and monocyte chemoattractant protein-1 gene polymorphisms in kidney transplant recipients. El-Gezawy EM; Eldin EN; Mohamed WS; Mahmoud MS; Saied SA; Abd El-Latif HH; Ibrahim MA Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):688-95. PubMed ID: 23816715 [TBL] [Abstract][Full Text] [Related]
13. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection. Ramsperger-Gleixner M; Spriewald BM; Tandler R; Kondruweit M; Amann K; Weyand M; Ensminger SM Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046 [TBL] [Abstract][Full Text] [Related]
14. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. Awad MR; Webber S; Boyle G; Sturchioĉ C; Ahmed M; Martell J; Law Y; Miller SA; Bowman P; Gribar S; Pigula F; Mazariegos G; Griffith BP; Zeevi A J Heart Lung Transplant; 2001 Jun; 20(6):625-30. PubMed ID: 11404167 [TBL] [Abstract][Full Text] [Related]